1 month Kura Oncology (NASDAQ:KURA) Coverage Initiated by Analysts at UBS GroupMarketBeat
UBS Group initiated coverage on shares of Kura Oncology in a research note on Thursday. They issued a “buy” rating and a $27.00 target price for the company.
X